Back to Dashboard

DSP-5336-101

ALL•NCT04988555•Last updated: 2/17/2026
Recruiting

Study Design

Study Drug

DSP-5336

Mechanism of Action

Menin inhibitor

Sponsor

Unknown

Design

I/ II

Control Arm

-

Criteria

Inclusion Criteria

4 cycle HMA/ LDAC or 2 cycle combination therapy failure for refractory group

Age: ≥18 years Phase: I/ II

Exclusion Criteria

Enrollment

Progress0 / 3

Contact Information

Principal Investigator

Unknown

Study Nurse

鄭采涵

Contact Tel

3974